Keywords: crucell, per, c6-based, west, nile, vaccine, good

Crucell's PER.C6-based West Nile Vaccine good in trials

Article | 05 February 2007

Print This

Dutch biotechnology company Crucell NV has completed a Phase I safety study with the alum adjuvanted formulation of its whole ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in